CASI Pharmaceuticals, Inc. (CASIF) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $25.65M | -52.2% |
| 2024 | $53.67M | -28.7% |
| 2023 | $75.27M | -21.8% |
| 2022 | $96.23M | -30.4% |
| 2021 | $138.30M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $25.65M | -52.2% |
| 2024 | $53.67M | -28.7% |
| 2023 | $75.27M | -21.8% |
| 2022 | $96.23M | -30.4% |
| 2021 | $138.30M | — |